Literature DB >> 30601991

The year in cardiology 2018: coronary interventions.

Dariusz Dudek1, Artur Dziewierz2, Gregg Stone3,4, William Wijns5.   

Abstract

Year:  2019        PMID： 30601991      PMCID： PMC6321963          DOI： 10.1093/eurheartj/ehy882

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  57 in total

1.  Comparison of a Novel Biodegradable Polymer Sirolimus-Eluting Stent With a Durable Polymer Everolimus-Eluting Stent: 5-Year Outcomes of the Randomized BIOFLOW-II Trial.

Authors:  Thierry Lefèvre; Michael Haude; Franz-Josef Neumann; Karl Stangl; Carsten Skurk; Ton Slagboom; Manel Sabaté; Javier Goicolea; Paul Barragan; Stéphane Cook; Jean-Christophe Macia; Stephan Windecker
Journal:  JACC Cardiovasc Interv       Date:  2018-05-28       Impact factor: 11.195

2.  The IMPACTOR-CTO Trial.

Authors:  Anton A Obedinskiy; Evgeny I Kretov; Marouane Boukhris; Vladislav P Kurbatov; Alexander G Osiev; Zied Ibn Elhadj; Nataliya R Obedinskaya; Sami Kasbaoui; Igor O Grazhdankin; Alexey A Prokhorikhin; Dmitry D Zubarev; Alexey Biryukov; Evgeny Pokushalov; Alfredo R Galassi; Vitaly I Baystrukov
Journal:  JACC Cardiovasc Interv       Date:  2018-07-09       Impact factor: 11.195

3.  Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial.

Authors:  Raban V Jeger; Ahmed Farah; Marc-Alexander Ohlow; Norman Mangner; Sven Möbius-Winkler; Gregor Leibundgut; Daniel Weilenmann; Jochen Wöhrle; Stefan Richter; Matthias Schreiber; Felix Mahfoud; Axel Linke; Frank-Peter Stephan; Christian Mueller; Peter Rickenbacher; Michael Coslovsky; Nicole Gilgen; Stefan Osswald; Christoph Kaiser; Bruno Scheller
Journal:  Lancet       Date:  2018-08-28       Impact factor: 79.321

4.  Left Main Revascularization With PCI or CABG in Patients With Chronic Kidney Disease: EXCEL Trial.

Authors:  Gennaro Giustino; Roxana Mehran; Patrick W Serruys; Joseph F Sabik; Milan Milojevic; Charles A Simonton; John D Puskas; David E Kandzari; Marie-Claude Morice; David P Taggart; Anthony H Gershlick; Philippe Généreux; Zixuan Zhang; Thomas McAndrew; Björn Redfors; Michael Ragosta; Irving L Kron; Ovidiu Dressler; Martin B Leon; Stuart J Pocock; Ori Ben-Yehuda; Arie Pieter Kappetein; Gregg W Stone
Journal:  J Am Coll Cardiol       Date:  2018-08-14       Impact factor: 24.094

5.  A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial.

Authors:  Robbert J de Winter; Yuki Katagiri; Taku Asano; Krzysztof P Milewski; Philipp Lurz; Pawel Buszman; Gillian A J Jessurun; Karel T Koch; Roland P T Troquay; Bas J B Hamer; Ton Oude Ophuis; Jochen Wöhrle; Rafał Wyderka; Guillaume Cayla; Sjoerd H Hofma; Sébastien Levesque; Aleksander Żurakowski; Dieter Fischer; Maciej Kośmider; Pascal Goube; E Karin Arkenbout; Michel Noutsias; Markus W Ferrari; Yoshinobu Onuma; William Wijns; Patrick W Serruys
Journal:  Lancet       Date:  2017-12-05       Impact factor: 79.321

6.  Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial.

Authors:  Dirk Sibbing; Dániel Aradi; Claudius Jacobshagen; Lisa Gross; Dietmar Trenk; Tobias Geisler; Martin Orban; Martin Hadamitzky; Béla Merkely; Róbert Gábor Kiss; András Komócsi; Csaba A Dézsi; Lesca Holdt; Stephan B Felix; Radoslaw Parma; Mariusz Klopotowski; Robert H G Schwinger; Johannes Rieber; Kurt Huber; Franz-Josef Neumann; Lukasz Koltowski; Julinda Mehilli; Zenon Huczek; Steffen Massberg
Journal:  Lancet       Date:  2017-08-28       Impact factor: 79.321

7.  B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial.

Authors:  Björn Redfors; Shmuel Chen; Aaron Crowley; Ori Ben-Yehuda; Bernard J Gersh; Nicholas J Lembo; W Morris Brown; Adrian P Banning; David P Taggart; Patrick W Serruys; Arie Pieter Kappetein; Joseph F Sabik; Gregg W Stone
Journal:  Circulation       Date:  2018-07-31       Impact factor: 29.690

8.  Temporal course of vascular healing and neoatherosclerosis after implantation of durable- or biodegradable-polymer drug-eluting stents.

Authors:  Giulio Guagliumi; Kunihiro Shimamura; Vasile Sirbu; Roberto Garbo; Giacomo Boccuzzi; Angelina Vassileva; Orazio Valsecchi; Luigi Fiocca; Paolo Canova; Francesco Colombo; Gabriel Tensol Rodriguez Pereira; Daisuke Nakamura; Guilherme F Attizzani; Alberto Cereda; Keisuke Satogami; Leonardo De Luca; Francesco Saia; Davide Capodanno
Journal:  Eur Heart J       Date:  2018-07-07       Impact factor: 29.983

9.  Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin Durable Polymer Everolimus-Eluting Stents.

Authors:  David E Kandzari; Jacques J Koolen; Gheorghe Doros; Joseph J Massaro; Hector M Garcia-Garcia; Johan Bennett; Ariel Roguin; Elie G Gharib; Donald E Cutlip; Ron Waksman
Journal:  J Am Coll Cardiol       Date:  2018-09-23       Impact factor: 24.094

10.  Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document.

Authors:  Hector M Garcia-Garcia; Eugène P McFadden; Andrew Farb; Roxana Mehran; Gregg W Stone; John Spertus; Yoshinobu Onuma; Marie-Angèle Morel; Gerrit-Anne van Es; Bram Zuckerman; William F Fearon; David Taggart; Arie-Pieter Kappetein; Mitchell W Krucoff; Pascal Vranckx; Stephan Windecker; Donald Cutlip; Patrick W Serruys
Journal:  Eur Heart J       Date:  2018-06-14       Impact factor: 29.983
View more
  1 in total

1.  Prospective multicentre open-label randomised controlled trial of 3-month versus 12-month dual antiplatelet therapy after implantation of the new generation biodegradable polymer sirolimus TARGET-eluting coronary stent: protocol of the TARGET DAPT trial.

Authors:  Hongbo Yang; Feng Zhang; Ji'e Yang; Ming Zheng; Ruifen Cao; Yuxiang Dai; Chenguang Li; Kang Yao; Juying Qian; Junbo Ge
Journal:  BMJ Open       Date:  2019-12-17       Impact factor: 2.692
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.